On 27 May, the 11th International Symposium on Lactic Acid Bacteria and Health
was held in Shijiazhuang City, Hebei Province. During this, Shijiazhuang
Junlebao Dairy Co., Ltd. (Junlebao Dairy), with the Chinese Institute of Food
Science and Technology (CIFST), initiated a "Probiotics Plus' strategy and
announced their joint establishment of an industry-academia integrated
probiotics research platform. This is aimed at advancing industrial
applications for probiotics in fields such as food and medical treatment, and
promoting the development of a probiotics health industry.
Source: Baidu
"Probiotics Plus' strategy
The probiotics industry is expected to grow strongly, reflecting its status as
a pioneer in the domestic food industry's shift towards a focus on
"nutritionals & health'. In 2014 global sales of products with probiotics
were estimated at USD28.8 billion, the meeting was told, with sales expected to
reach USD42 billion this year.
The "Probiotics Plus' strategy, initiated by Junlebao Dairy and CIFST, also
involves a range of experts in China and overseas. "This strategy is aimed at
promoting the industry's joint action, and combined industry and academic
research,' stated Shao Wei, Secretary General of CIFST: "It will meet the
public's demand for better health, fit in with the expected changes in industry
structure and speed up R&D, innovation and their application for the good
of consumers.'
Zhong Yan, CEO of Junlebao Dairy, listed 3 reasons for initiating the
"Probiotics Plus" strategy:
Consumers are increasingly demanding
healthy lifestyles. Lactic acid bacteria (LAB) and "Probiotics' and "Longevity
Bacteria' are widely recognised has having scientific credibility and are
sought out by consumers as a result
It is inevitable that the food industry
will orient itself towards "nutritionals & health', and this will be key to
the dairy industry as it restructures
There are various probiotic products in
China, but few use domestically-developed probiotic strains. The company
intends to strategically extend its own business, in doing so taking
responsibility for advancing the whole industry's development
Junlebao Dairy: 21 years in the probiotics business
At the symposium, Junlebao Dairy was awarded the prize for "Innovative LAB
Industry Product in 2015-2016' for its Purjoy flavoured probiotic yoghurt. Its
quality and taste were both spoken highly of by the experts present, supporting
the company's leading role in the probiotics industry.
It has focused on the LAB business since 1995 when it was founded, since when
it has accumulated rich knowhow about related technologies, R&D, strain
cultivation etc. It has succeeded in developing 3 product ranges - Viable,
Purjoy and Le Chang365 (which includes probiotics + prebiotics) - and star
products which include Purjoy (yoghurt), Viable (LAB beverage), Jun Chang (LAB
beverage) and Kefir (yoghurt).
It is particularly active in the LAB beverage
segment, where it takes 3rd place together with Weiquan and Yili, each with
sales at about 10% (behind Yakult 37%, Mengniu 22%).
The company has patented its L. paracasei N1115 and accordingly operates across
the full probiotic supply chain. On 11 May, CIFST organised experts to assess
the L. Paracasei N1115 Functional Research and Industrialisation Project, with
its effect on reducing blood fats and enhancing immunity being accepted. "The
strain and its products, at internationally advanced level, have bright
application prospects,' the experts asserted.
Junlebao Dairy is a regional dairy company located in Hebei Province, founded
in 1995. In the Opinions on Accelerating Dairy Industry Development in Hebei
Province, its important position in the province is clear: "By 2017, the
province will have 2-3 dairy companies including Junlebao Dairy, capable of
producing at least 50,000 tonnes of infant formulas per year." Evidently,
the company is strongly supported by the government.
This is not surprising, as the company has certainly grown rapidly. In January
2010 when Mengniu acquired the company its turnover was estimated at just
USD139.6 million (RMB920 million), however in 2015 its sales exceeded USD910.6
million (RMB6 billion). As a company dedicated to technology innovation, deeply
involved in the probiotics business and supported by the government, its
prospects appear very promising.
This article comes from Dairy Products China News 1606, CCM
About CCM:
CCM is the
leading market intelligence provider for China's agriculture, chemicals, food
& ingredients and life science markets. Founded in 2001, CCM offers a
range of data and content solutions, from price and trade data to industry
newsletters and customized market research reports. Our clients include Monsanto,
DuPont, Shell, Bayer, and Syngenta. CCM is a brand of Kcomber Inc.
For more
information about CCM, please visit www.cnchemicals.com or get in touch with us
directly by emailing econtact@cnchemicals.com or calling
+86-20-37616606.
Tag: Dairy